TY - JOUR
T1 - Use of Complementary and Integrative Medicine Among Patients With Glioblastoma Multiforme Seen at a Tertiary Care Center
AU - Munoz-Casabella, Amanda
AU - Wahner-Roedler, Dietlind L.
AU - Croghan, Ivana T.
AU - Petterson, Tanya M.
AU - Fuehrer, Debbie L.
AU - Bauer, Brent A.
N1 - Funding Information:
We thank the Mayo Clinic Survey Research Center, especially Libby J. Hammond and Ann M. Harris, for formatting and preparing the survey; Debra S. Albrecht, Laurie L. Prince, and Melissa S. Rathbun for monitoring and capturing data from the returned surveys; and Kandace A. Lackore for assisting with the data programming and analysis. Without their assistance, this study would not have been possible. June Oshiro, PhD, ELS, Mayo Clinic, substantively edited the manuscript. The Scientific Publications staff at Mayo Clinic provided proofreading, administrative, and clerical support. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported in part by The Head Foundation, Singapore (Dr Bauer’s time) and by the Integrative Medicine Program, Rochester, Minnesota (survey and statistical support).
Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported in part by The Head Foundation, Singapore (Dr Bauer’s time) and by the Integrative Medicine Program, Rochester, Minnesota (survey and statistical support).
Publisher Copyright:
© The Author(s) 2022.
PY - 2022/2/11
Y1 - 2022/2/11
N2 - Background: Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12–15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective: To determine the prevalence of CIM use and identify the most frequently used types of CIM in a cohort of patients with GBM seen at a tertiary care medical center in the United States. Methods: An anonymous survey was mailed through the US Postal Service from August 1, 2019, through February 21, 2020, to patients with GBM. Results: A total of 346 surveys were mailed, and 146 responses (42%) were received. The median age of respondents was 61 years (range, 52–68 years), and 85 (58%) were male. Most patients had undergone surgery (90%), chemotherapy (96%), and radiotherapy (95%). The median time from diagnosis of GBM to survey participation was 18 months (range, 12–31 months). Most respondents (81%) used some form of CIM, most frequently meditation (22%), relaxation and other stress management techniques (19%), chiropractic therapy (16%), and acupuncture (12%). Compared with men, women more commonly meditated (32% vs 16%; P =.046) and practiced yoga (20% vs 6%; P =.04). We observed age-based differences, with younger patients more commonly meditating, practicing relaxation and stress management techniques, and receiving chiropractic therapy (P <.05 for all). Conclusions: Providers should encourage patients with GBM to discuss their interest in CIM therapies and guide them to evidence-based treatments that may help improve their quality of life.
AB - Background: Glioblastoma multiforme (GBM) is among the most aggressive and lethal tumors, with a median survival of 12–15 months. Many patients use complementary and integrative medicine (CIM) therapies to supplement their cancer treatment. Objective: To determine the prevalence of CIM use and identify the most frequently used types of CIM in a cohort of patients with GBM seen at a tertiary care medical center in the United States. Methods: An anonymous survey was mailed through the US Postal Service from August 1, 2019, through February 21, 2020, to patients with GBM. Results: A total of 346 surveys were mailed, and 146 responses (42%) were received. The median age of respondents was 61 years (range, 52–68 years), and 85 (58%) were male. Most patients had undergone surgery (90%), chemotherapy (96%), and radiotherapy (95%). The median time from diagnosis of GBM to survey participation was 18 months (range, 12–31 months). Most respondents (81%) used some form of CIM, most frequently meditation (22%), relaxation and other stress management techniques (19%), chiropractic therapy (16%), and acupuncture (12%). Compared with men, women more commonly meditated (32% vs 16%; P =.046) and practiced yoga (20% vs 6%; P =.04). We observed age-based differences, with younger patients more commonly meditating, practicing relaxation and stress management techniques, and receiving chiropractic therapy (P <.05 for all). Conclusions: Providers should encourage patients with GBM to discuss their interest in CIM therapies and guide them to evidence-based treatments that may help improve their quality of life.
KW - alternative medicine
KW - cancer
KW - complementary medicine
KW - glioblastoma
KW - glioblastoma multiforme
KW - integrative medicine
UR - http://www.scopus.com/inward/record.url?scp=85127265742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127265742&partnerID=8YFLogxK
U2 - 10.1177/2164957X221078543
DO - 10.1177/2164957X221078543
M3 - Article
AN - SCOPUS:85127265742
SN - 2164-957X
VL - 11
JO - Global Advances In Health and Medicine
JF - Global Advances In Health and Medicine
ER -